文献速递肺栓塞与肺血管病

CAMPHOR评分:肺动脉内膜剥脱术改善慢性血栓栓塞性肺动脉高压患者报告结局

CAMPHOR score: patient-reported outcomes are improved by pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension.
PubMed 文献 · Eur Respir J · 2020-10-01

这项回顾性观察研究纳入2006至2017年英国国家PEA中心接受PEA的CTEPH患者,评估CAMPHOR评分从术前至术后5年变化。结果显示PEA后活动、生活质量和症状三个领域均显著改善,无临床显著残留肺高压者改善更大更持久,且手术者评分优于未手术倾向匹配者。

要点

  • PEA术后CAMPHOR活动、生活质量、症状评分均显著改善。
  • 无临床显著残留肺高压者改善幅度更大且更持久。
  • PEA患者CAMPHOR评分优于未手术的倾向匹配CTEPH患者。

核心结论

  • PEA可显著改善CTEPH患者的患者报告结局,无临床显著残留肺高压者改善更明显。

研究设计与样本

  • 回顾性观察研究,纳入2006至2017年英国国家PEA中心连续接受PEA的CTEPH患者1324例。

主要发现

  • PEA前后三个CAMPHOR领域均显著改善:活动中位数±IQR -5±7,生活质量-4±8,症状-7±8,均p<0.0001。
  • 无临床显著残留肺高压者CAMPHOR评分改善更大且更持久。
  • 接受PEA的CTEPH患者CAMPHOR评分优于未手术的倾向匹配患者。

关键数值与推荐

  • CAMPHOR最小临床重要差异:活动-3±5,生活质量-4±7,症状-6±7。

临床怎么用

  • 可将CAMPHOR评分用于CTEPH患者PEA术前评估和术后随访,关注活动、生活质量和症状变化。

局限性

  • 回顾性观察设计,部分患者缺少术前或术后CAMPHOR评分记录。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pulmonary endarterectomy (PEA) is the recommended treatment for eligible patients with chronic thromboembolic pulmonary hypertension (CTEPH). The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) score is an internationally validated patient-reported outcome (PRO) measure for CTEPH. It assesses three domains: activity, quality of life (QoL) and symptoms. We assessed PROs in patients with CTEPH undergoing PEA. METHODS: This retrospective observational study of consecutive CTEPH patients undergoing PEA at the UK national PEA centre between 2006 and 2017 assessed change in CAMPHOR score from baseline (pre-PEA) until up to 5 years post-PEA. CAMPHOR scores were compared between 1) those with and without clinically significant residual pulmonary hypertension and 2) those undergoing PEA and propensity-matched CTEPH patients who were not operated on. The minimally clinically important difference (MCID) was calculated using an anchor-based method. RESULTS: Out of 1324 CTEPH patients who underwent PEA, 1053 (80%) had a CAMPHOR score recorded pre-PEA, 934 (71%) had a score recorded within a year of PEA and 784 (60%) had both. There were significant improvements between pre- and post-PEA in all three CAMPHOR domains (median±interquartile range activity -5±7, QoL -4±8, symptoms -7±8; all p<0.0001). Improvements in CAMPHOR score were greater and more sustained in those without clinically significant residual pulmonary hypertension. CTEPH patients undergoing PEA had better CAMPHOR scores than those not operated on. The MCID in CAMPHOR score was -3±5 for activity, -4±7 for QoL and -6±7 for symptoms. CONCLUSIONS: PROs are markedly improved by PEA in patients with CTEPH, more so in those without clinically significant residual pulmonary hypertension.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Newnham M, Bunclark K, Abraham N, et al. CAMPHOR score: patient-reported outcomes are improved by pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension. Eur Respir J. 2020. PMID: 32513780. doi:10.1183/13993003.02096-2019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。